Vertex Pharmaceuticals (VRTX) Shares Repurchased (2018 - 2026)

Vertex Pharmaceuticals has reported Shares Repurchased for 8 years, with the latest figure at $336.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Repurchased fell 20.93% year-over-year to $336.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 billion (up 30.99% YoY), and the FY2025 full-year result was $2.0 billion, up 71.39% from the prior year.
• Shares Repurchased for Q1 2026 stood at $336.9 million, up from $128.4 million in the prior quarter.
• The five-year high for Shares Repurchased was $1.1 billion in Q3 2025, with the low at $28.3 million in Q2 2023.
• Average Shares Repurchased over 4 years is $304.5 million, with a median of $307.7 million recorded in 2024.
• Year-over-year, Shares Repurchased jumped 1031.8% in 2024 and slumped 69.27% in 2025.
• Tracing VRTX's Shares Repurchased over 4 years: stood at $149.5 million in 2023, then jumped by 179.53% to $417.9 million in 2024, then tumbled by 69.27% to $128.4 million in 2025, then soared by 162.38% to $336.9 million in 2026.
• The last three Shares Repurchased figures came in at $336.9 million (Q1 2026), $128.4 million (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.

Peer Comparison